Atlas Trials

Hypofractionated vs. Conventionally Fractionated Concurrent CRT for Unresectable Stage III NSCLC

Clinical trial NCT03331575 · UNKNOWN

Trial details

NCT number
NCT03331575
Sponsor
Shanghai Chest Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Unresectable Stage III Non-small-cell Lung Cancer
Start date
2017-11-01
Primary completion
2020-11-01
Enrollment
480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.